Related Experiment Video
Updated: Jun 8, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease
Valerie Waters1, Yvonne Yau, Sudha Prasad
1Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada. valerie.waters@sickkids.ca
Rationale:
Stenotrophomonas maltophilia is one of the more common multidrug-resistant organisms isolated from the respiratory tract of patients with cystic fibrosis (CF), but the effect of chronic S. maltophilia infection on CF lung disease is unknown.
Objectives:
To determine the impact of chronic S. maltophilia infection on lung disease in CF.
Methods:
We developed a serologic assay specific for S. maltophilia and in a cross-sectional study, measured serum antibodies to S. maltophilia in patients with CF to determine if a definition of chronic S. maltophilia isolation based on culture results corresponded to an immunologic response (serologic study). We then used this validated definition to examine the effect of chronic S. maltophilia on the severity of lung disease in a retrospective cohort study using the Toronto CF Database from 1997-2008 (cohort study).
Measurements And Main Results:
Serum antibody levels to S. maltophilia were measured in 179 patients with CF. Patients with chronic S. maltophilia had significantly higher mean antibody levels to S. maltophilia flagellin (P < 0.0001) and whole cell (P = 0.0004) compared with patients with intermittent or no S. maltophilia. The cohort study included 692 patients with an average follow-up of 8.3 years. In an adjusted log linear model, patients with chronic S. maltophilia infection had a significantly increased risk of pulmonary exacerbation requiring hospitalization and antibiotics compared with patients who had never had S. maltophilia (relative risk = 1.63; P = 0.0002).
Conclusions:
Chronic S. maltophilia infection in patients with CF is associated with a specific immune response to this organism and is an independent risk factor for pulmonary exacerbations.
Insights
Chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patients triggers an immune response. This chronic infection independently increases the risk of pulmonary exacerbations, impacting lung disease severity.
Area of Science:
- Medical Microbiology
- Pulmonology
- Immunology
Background:
- Stenotrophomonas maltophilia is a common multidrug-resistant organism in cystic fibrosis (CF) respiratory tracts.
- The impact of chronic S. maltophilia infection on CF lung disease progression remains unclear.
Purpose of the Study:
- To investigate the effect of chronic S. maltophilia infection on lung disease in patients with CF.
- To establish a validated definition for chronic S. maltophilia isolation.
Main Methods:
- Developed a serologic assay to detect S. maltophilia antibodies.
- Conducted a cross-sectional study to correlate culture results with immune response.
- Performed a retrospective cohort study using the Toronto CF Database (1997-2008) to assess disease severity.
Main Results:
- Patients with chronic S. maltophilia showed significantly higher antibody levels to flagellin and whole cells.
- Chronic infection was associated with a 1.63-fold increased risk of pulmonary exacerbations requiring hospitalization.
- The cohort study included 692 CF patients with an average follow-up of 8.3 years.
Conclusions:
- Chronic S. maltophilia infection in CF patients elicits a specific immune response.
- Chronic S. maltophilia is an independent risk factor for pulmonary exacerbations in CF patients.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Atypical Pneumonia
Cryptococcal Meningitis

